Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Greening critical care by harnessing the planetary impact of medications: What fellows need to know.

Journal of critical care·2026
Same author

Wood burning also contributes to climate change.

BMJ (Clinical research ed.)·2026
Same author

Environmental risk factors and cardiovascular health.

European heart journal·2026
Same author

The Impact of Wildfire Smoke on Acute Cardiovascular and Respiratory Illness in the US.

Research square·2026
Same author

Climate change threatens survival-will warnings from economists and intelligence services at last move us to act?

BMJ (Clinical research ed.)·2026
Same author

The physiology of survival: Breath-hold shallow-water diving.

Experimental physiology·2025
Same journal

Diving exposure and pulmonary stress.

The Journal of physiology·2026
Same journal

Systems modelling of mitochondrial dynamics in different exercise regimes.

The Journal of physiology·2026
Same journal

Central leptin resistance precedes obesity and drives early endocrine dysfunction.

The Journal of physiology·2026
Same journal

Decoding the molecular memory of obesity using machine learning and microRNA dynamics.

The Journal of physiology·2026
Same journal

Kinematic-calcium loops unravel impaired excitation-contraction coupling in MELAS-affected cardioids.

The Journal of physiology·2026
Same journal

hERG1 channels and potential therapeutics for long QT syndrome.

The Journal of physiology·2026
See all related articles

Related Experiment Video

Updated: Jun 7, 2026

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
09:44

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

Published on: April 12, 2011

Structure to function: muscle failure in critically ill patients.

Zudin Puthucheary1, Hugh Montgomery, John Moxham

  • 1Institute for Human Health and Performance, University College London and Division of Asthma Allergy and Lung Biology, Kings College London, London, UK. nicholas.hart@gstt.nhs.uk

The Journal of Physiology
|October 22, 2010
PubMed
Summary
This summary is machine-generated.

Critically ill patients often experience muscle wasting, impacting physical function and survival. Research is growing to understand the complex physiological factors behind muscle loss in intensive care unit (ICU) survivors.

More Related Videos

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice
04:01

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice

Published on: June 14, 2024

3D Ultrasound Imaging: Fast and Cost-effective Morphometry of Musculoskeletal Tissue
08:52

3D Ultrasound Imaging: Fast and Cost-effective Morphometry of Musculoskeletal Tissue

Published on: November 27, 2017

Related Experiment Videos

Last Updated: Jun 7, 2026

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
09:44

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

Published on: April 12, 2011

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice
04:01

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice

Published on: June 14, 2024

3D Ultrasound Imaging: Fast and Cost-effective Morphometry of Musculoskeletal Tissue
08:52

3D Ultrasound Imaging: Fast and Cost-effective Morphometry of Musculoskeletal Tissue

Published on: November 27, 2017

Area of Science:

  • Critical care medicine
  • Physiology
  • Muscle biology

Background:

  • Intensive care unit (ICU) survivors frequently exhibit impaired physical function and reduced activity.
  • Reduced muscle strength in critical illness is a significant predictor of survival.
  • Skeletal muscle wasting is a suspected cause of functional decline, but underlying mechanisms in critically ill patients are poorly understood.

Purpose of the Study:

  • To highlight challenges in measuring muscle mass and function in critically ill patients.
  • To review existing data on physiological mechanisms regulating muscle mass and function.
  • To propose a rational approach to understanding muscle wasting in critical illness.

Main Methods:

  • Review of animal and healthy human data.
  • Discussion of physiological complexities in studying critically ill patients.
  • Identification of risk factors for muscle wasting.

Main Results:

  • Measurement of muscle mass and function in ICU patients presents significant technical challenges.
  • Patient heterogeneity complicates the interpretation of research findings.
  • Established risk factors for muscle wasting (aging, immobility, inflammation) are prevalent in ICU populations.

Conclusions:

  • Understanding muscle wasting in critical illness is crucial due to its impact on survival and function.
  • Further research is needed to elucidate the specific pathophysiological mechanisms in critically ill patients.
  • Addressing factors like immobility and inflammation may be key to mitigating muscle loss.